20
Participants
Start Date
August 13, 2020
Primary Completion Date
August 1, 2021
Study Completion Date
August 1, 2021
Angiotensin II
If intraoperative or postoperative hypotension occurs (e.g. SBP \< 120 mmHg) and the attending surgeon and/or attending anesthesiologist deems vasopressor therapy to be necessary, angiotensin II (Giapreza) will be the first vasopressor used for management.
University of Illinois Hospital and Health Sciences System, Chicago
Collaborators (1)
La Jolla Pharmaceutical Company
INDUSTRY
University of Illinois at Chicago
OTHER